# Efficacy and Safety of Continuous Versus Intermittent Nebulization of Salbutamol in Acute Severe Asthma in Children Under 12 Years of Age

> **NCT06754631** · NA · COMPLETED · sponsor: **Muhammad Aamir Latif** · enrollment: 120 (actual)

## Conditions studied

- Asthma in Children

## Interventions

- **DRUG:** Continuous Nebulization of Salbutamol
- **DRUG:** Intermittent Nebulization of Salbutamol

## Key facts

- **NCT ID:** NCT06754631
- **Lead sponsor:** Muhammad Aamir Latif
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-01
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-01-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06754631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06754631, "Efficacy and Safety of Continuous Versus Intermittent Nebulization of Salbutamol in Acute Severe Asthma in Children Under 12 Years of Age". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06754631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*